P2RY12 and type 2 diabetes mellitus: Long‐term (up to 12 months) dual antiplatelet therapy, comprising acetylsalicylic acid (ASA) and a P2Y12 inhibitor (clopidogrel, prasugrel or ticagrelor), is widely used to prevent recurrent ischaemic events in patients with T2D and acute coronary syndrome.3, 4, 5